Animal Drug User Fee Act; Public Meeting; Request for Comments

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.

The commenter opposes the current structure of the Animal Drug User Fee Act (ADUFA) because it focuses on pre-market review rather than post-marketing surveillance and compliance. They argue that the FDA lacks sufficient authorities to manage safety risks after a drug is on the market and call for stronger oversight and safeguards to protect human and animal health.

An individual commenter supports the proposed action by urging the FDA to seek greater authority from Congress to address antibiotic resistance and public health risks associated with veterinary drugs in food animals.

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.

The commenter supports the ADUFA reauthorization but argues that it should include provisions to prohibit the use of antibiotics in healthy animals. They urge the FDA to seek congressional authority to implement these restrictions without lengthy hearings.